Truist Securities Downgrades POINT Biopharma Global Inc. (PNT) to Hold Following Takeover
Tweet Send to a Friend
Truist Securities analyst Nicole Germino downgraded POINT Biopharma Global Inc. (NASDAQ: PNT) from Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
